(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]21

CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]21

Cardiac fibroblasts (CFs) are cultured in HG medium with varying concentrations of Neferine (1

H2O/c1-12-17(27(19

Daily oral doses of 10 to 30 mg/kg of Timegadine significantly inhibit both the primary and secondary lesions of adjuvant arthritis when the treatment is initiated on the day of the disease induction and continues for 28 days

than those in mice fed 0%

(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]21(3R,5R) Rosuvastatin is the (3R,5R) enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG CoA reductase inhibitor with an IC50 of 11 nM. Rosuvastatin potently blocks human ether a go go related gene (hERG) current with an IC50 of 195 nM. Rosuvastatin reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin is very effective in lowering low density lipoprotein (LDL)